April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 29, 2026
Drug Delivery Nanoparticles Formulation Market (By Nanoparticle Type: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Inorganic Nanoparticles, Dendrimers, Carbon-Based Nanoparticles; By Drug Type: Small Molecules, Biologics, Nucleic Acid-Based Drugs; By Application: Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders,...
April 21, 2026
Market insights predict, the APAC pharmaceutical industry is expected to grow from USD 434.19 billion in 2024 to USD 855.68 billion by 2034, driven by a CAGR of 7.02%. The rising prevalence of chronic disorders and the increasing need for personalized medicines bolster market growth. China’s dominance in the market is attributed to the strong...
April 21, 2026
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patient-specific therapies, is estimated to drive the growth of the market. North America led the global ...
April 21, 2026
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral vector CDMO including therapeutic development and clinical trials drive the expansion of these organ...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing demand for personalized medicines bolster market growth. The availability of state-of-the-art resear...
April 21, 2026
According to market projections, the serum gonadotrophin API sector is expected to grow from USD 131 million in 2024 to USD 202.93 million by 2034, reflecting a CAGR of 4.64%. The market is growing due to rising demand for fertility treatment and assisted reproductive technologies. Additionally, the increasing prevalence of infertility and the expa...
April 21, 2026
Based on market forecasts, the sports herbal supplements sector will expand from USD 2.42 billion in 2024 to USD 4.42 billion by 2034, experiencing a CAGR of 6.54%. The sports herbal supplements market is growing as it enhances endurance and stamina, improves strength and recovery, stress reduction and mental focus, energy levels, and metabolism. N...
April 21, 2026
Market insights predict the global drug-loaded fat emulsion industry will increase from USD 2.34 billion in 2024 to USD 7.25 billion by 2034, achieving a CAGR of 12.04%. The principal advantages of these delivery systems, including versatile administration routes, drive the growth of drug-loaded fat emulsions. North America dominated the market in ...
April 21, 2026
According to market projections, the steroid hormone API sector is expected to grow from USD 3.54 billion in 2024 to USD 6.06 billion by 2034, reflecting a CAGR of 5.54%. The steroid hormone API market is growing due to rising demand for natural steroids. Europe is dominating the market due to the rising production of various natural and synthetic ...
April 21, 2026
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing demand for personalized medicines bolster market growth. North America dominated the global market d...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
